BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+19.43%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$4B
AUM Growth
+$4B
Cap. Flow
-$156M
Cap. Flow %
-3.89%
Top 10 Hldgs %
61.89%
Holding
76
New
7
Increased
10
Reduced
7
Closed
6

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$57.4M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
$40.5M
3
ACIU icon
AC Immune
ACIU
$35.7M
4
ANNX icon
Annexon
ANNX
$31.8M
5
ETNB icon
89bio
ETNB
$24.6M

Top Sells

1
IDYA icon
IDEAYA Biosciences
IDYA
$126M
2
IONS icon
Ionis Pharmaceuticals
IONS
$79.7M
3
PNT
POINT Biopharma Global Inc. Common Stock
PNT
$70.5M
4
ACRS icon
Aclaris Therapeutics
ACRS
$48.4M
5
XENE icon
Xenon Pharmaceuticals
XENE
$43.2M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ELDN icon
51
Eledon Pharmaceuticals
ELDN
$155M
$7.79M 0.19%
4,326,710
– –
SABS icon
52
SAB Biotherapeutics
SABS
$21.6M
$6.31M 0.16%
+9,178,282
New +$6.31M
VIGL
53
DELISTED
Vigil Neuroscience
VIGL
$6.13M 0.15%
1,813,633
– –
CDTX icon
54
Cidara Therapeutics
CDTX
$1.61B
$5.45M 0.14%
6,861,127
– –
RAIN
55
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$4.23M 0.11%
3,526,729
– –
DCTH icon
56
Delcath Systems
DCTH
$381M
$4.06M 0.1%
976,149
– –
PVLA
57
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$3.75M 0.09%
20,609,863
– –
KRON
58
DELISTED
Kronos Bio
KRON
$3.63M 0.09%
2,905,043
– –
NLSP icon
59
NLS Pharmaceutics
NLSP
$9.96M
$3.39M 0.08%
5,747,126
– –
IVA
60
Inventiva
IVA
$802M
$3.07M 0.08%
686,040
– –
FBRX icon
61
Forte Biosciences
FBRX
$138M
$2.45M 0.06%
2,982,105
– –
CRVS icon
62
Corvus Pharmaceuticals
CRVS
$419M
$2.41M 0.06%
1,370,947
– –
VIRX
63
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.06M 0.05%
3,614,662
– –
MTEM
64
DELISTED
Molecular Templates, Inc.
MTEM
$1.97M 0.05%
532,038
– –
UNCY icon
65
Unicycive Therapeutics
UNCY
$75.8M
$1.84M 0.05%
2,118,139
-1,295,424
-38% -$1.12M
MOLN
66
Molecular Partners
MOLN
$139M
$1.76M 0.04%
443,221
– –
ELEV
67
DELISTED
Elevation Oncology
ELEV
$1.24M 0.03%
2,312,200
– –
ENGNW icon
68
enGene Holdings Inc. Warrants
ENGNW
$7.29M
$804K 0.02%
+945,402
New +$804K
ASLN
69
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$548K 0.01%
1,049,999
– –
RZLT icon
70
Rezolute
RZLT
$630M
$189K ﹤0.01%
190,815
– –
ACRS icon
71
Aclaris Therapeutics
ACRS
$223M
– –
-7,064,736
Closed -$48.4M
IMUX icon
72
Immunic
IMUX
$79.4M
– –
-1,149,425
Closed -$1.69M
JSPR icon
73
Jasper Therapeutics
JSPR
$44.2M
– –
-9,900,000
Closed -$6.93M
REPL icon
74
Replimune Group
REPL
$460M
– –
-2,143,036
Closed -$36.7M
NEUP
75
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
– –
-47,372
Closed -$128K
1 2
3
4